Insider Trading History of Marguglio David J.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Marguglio David J. since year 2005. The trader's CIK number is 1461753. At the time of the last reporting, Marguglio David J. was the Sr VP of Business Development of Adamis Pharmaceuticals Corp . (stock ticker symbol ADMP). See this page for all insider trading activities at Adamis Pharmaceuticals Corp .


Stock purchases, sales, and option exercises reported by insider Marguglio David J. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-03-20 ADMP Adamis Pharmaceuticals Corp Sale 10,579 2.28 24,109
2019-02-21 ADMP Adamis Pharmaceuticals Corp Option Ex 22,258 .00 0
2016-06-02 ADMP Adamis Pharmaceuticals Corp Sale 700 9.00 6,301
2016-05-16 ADMP Adamis Pharmaceuticals Corp Sale 4,000 8.09 32,340
2016-05-09 ADMP Adamis Pharmaceuticals Corp Sale 4,860 10.00 48,600
2016-05-03 ADMP Adamis Pharmaceuticals Corp Sale 1,140 9.00 10,260
2016-04-14 ADMP Adamis Pharmaceuticals Corp Sale 12,000 7.52 90,216
2015-04-20 ADMP Adamis Pharmaceuticals Corp Sale 200 5.00 1,000
2015-04-17 ADMP Adamis Pharmaceuticals Corp Sale 100 5.01 501
2015-04-16 ADMP Adamis Pharmaceuticals Corp Sale 700 5.00 3,500
2015-04-13 ADMP Adamis Pharmaceuticals Corp Sale 2,100 5.01 10,525
2015-04-14 ADMP Adamis Pharmaceuticals Corp Sale 100 5.00 500
2015-03-04 ADMP Adamis Pharmaceuticals Corp Sale 11,800 7.09 83,662
2015-03-02 ADMP Adamis Pharmaceuticals Corp Sale 7,000 6.45 45,150
2015-01-08 ADMP Adamis Pharmaceuticals Corp Sale 200 7.00 1,400
2015-01-05 ADMP Adamis Pharmaceuticals Corp Sale 7,000 6.18 43,260
2014-12-30 ADMP Adamis Pharmaceuticals Corp Sale 12,228 6.09 74,468
2014-12-29 ADMP Adamis Pharmaceuticals Corp Sale 772 6.00 4,632
2014-12-12 ADMP Adamis Pharmaceuticals Corp Sale 4,000 5.18 20,740
2014-09-02 ADMP Adamis Pharmaceuticals Corp Sale 8,000 5.06 40,472
2014-06-02 ADMP Adamis Pharmaceuticals Corp Sale 4,000 5.56 22,256

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marguglio David J. (Sr VP of Business Development of Adamis Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.